XP Power Ltd. (LSE:XPP), the designer of power converters for semiconductor equipment, medical devices and industrial machinery, has spent two years shrinking its debt, closing factories and waiting for customers to stop running down inventory. Its half-year results on 4 August 2026 suggest the wait may be ending: order intake jumped 55% at constant currency to £167.2m, the book-to-bill ratio hit 1.53x, its highest since the first half of 2022, and £135m of firm orders are already scheduled for second-half delivery.

The question for 2026 is whether that order surge, driven largely by AI-related wafer fabrication spending, converts into the Revenue and Margin recovery the company has promised, and what becomes of a long-running US legal dispute that took an unexpected turn in July.

Interim results: orders up 55%, profit recovers on flat revenue

The six months to 30 June 2026 produced revenue of £109.1m, marginally below the £110.9m reported a year earlier but 2% higher at constant currency after a weaker US dollar clipped around four percentage points from reported growth. The story was in the margin line. Adjusted gross margin expanded 450 basis points to 45.9%, adjusted operating profit rose 79% to £8.6m and adjusted profit before tax climbed to £5.1m from £0.8m. On a reported basis the group swung to a pre-tax profit of £2.0m from a £1.4m loss, with Diluted Earnings per Share of 3.6p against a 7.2p loss.

Semiconductor Manufacturing Equipment, now 40% of revenue, delivered the standout numbers: orders of £79.9m, up 116% at constant currency, for a record sector book-to-bill of 1.81x, attributed to capacity expansion for AI-driven wafer fabrication. Industrial Technology, 41% of revenue, grew sales 9% at constant currency as destocking ended. Healthcare revenue fell 13% to £20.4m, although a book-to-bill of 1.36x suggests orders are running well ahead of shipments.

Chief executive Gavin Griggs said: "Strong order intake in H1 underpins robust revenue growth expectations for H2, reflecting both market recovery and our strategic product investments in technically complex categories." Full-year expectations were unchanged, with Leverage expected to approach 1.0x adjusted EBITDA by year-end.

What XP Power does

XP Power designs and manufactures power conversion products, the components that turn mains electricity into the precisely regulated voltages sensitive equipment requires. Its catalogue spans AC-DC power supplies, DC-DC converters, high-voltage supplies up to 500kV, EMI filters and custom solutions, sold to original equipment manufacturers in semiconductor manufacturing equipment, industrial technology (including robotics and analytical instruments) and healthcare.

North America generated £67.5m of first-half 2026 revenue, Europe £32.9m and Asia £8.7m. Asian revenue fell 11% as the group exited the China semiconductor market and a US export licence for radio-frequency products expired; the RF line, worth £24.3m of 2025 revenue, is being wound down over roughly three years. Manufacturing is now concentrated in Vietnam and a new Malaysian plant due for full production in the fourth quarter of 2026, after the China factory closed at the end of 2025.

Full-year 2025: a trough year, but net Debt more than halved

The 2025 annual results, published on 3 March 2026, showed the scale of the downturn. Revenue for the year to 31 December 2025 fell 4% at constant currency to £230.1m from £247.3m, and adjusted operating profit dropped 20% to £17.3m from £25.1m. Adjusted diluted earnings per share almost halved to 22.5p from 42.9p, while the reported result was a loss of 42.0p per share after a £7.3m pre-tax loss that included restructuring and other adjusting items.

The Balance Sheet moved the other way. Operating Cash Flow of £38.9m, helped by a 20% cut in inventory to £57.0m, reduced net debt to £41.5m from £93.5m and leverage to 1.2x adjusted EBITDA from 2.3x, while order intake rose 28% at constant currency to £225.9m.

Net debt then rose to £47.7m at 30 June 2026, with leverage at 1.3x, as inventory was rebuilt to £73.8m to service the second-half order book and Capital went into the Malaysian site; first-half operating cash flow fell to £8.4m from £13.9m. No Interim Dividend was declared: payments have been suspended since late 2023 and reinstatement will only be considered once leverage sits within the 0-1x target range.

What could drive the stock next

The most immediate catalyst is delivery. With £135m of firm orders scheduled for the second half, against first-half revenue of £109.1m, the third-quarter trading update, due around October on the company's usual calendar, will show whether the Vietnam and Malaysia plants can ship at the required pace and whether margins hold.

The Comet litigation is a potential swing factor. On 15 July 2026, the US Court of Appeals for the Ninth Circuit reversed a 2022 District Court judgment in favour of Comet Technologies and ordered a new trial, vacating roughly US$40m of damages, more than US$17m of attorney fees and a permanent injunction. The money remains held in a bond with the District Court, and full-year leverage guidance excludes any benefit from its release. A favourable retrial or settlement could accelerate deleveraging and a return to dividends; the company has said only that it "will continue to defend its position."

Beyond that, promotion to the FTSE 250 on 6 May 2026 broadens the potential investor base and the sale of the closed Chinese factory is expected to complete in the second half. Management's medium-term framework targets roughly 10% organic growth and a 20% adjusted operating margin, both well ahead of 2025 levels.

Risks investors should watch

Concentration in semiconductor equipment cuts both ways. The sector supplies 40% of revenue and almost half of orders, and a pause in AI-related fab Investment would quickly reverse the book-to-bill improvement. Healthcare revenue is already falling.

The Comet retrial is unresolved and could yet produce a fresh adverse judgment. Tariff policy remains fluid: US tariffs on Vietnamese-made goods were set at 20% in April 2025, ruled invalid in February 2026 and replaced by a 10% global regime, and passing the cost on to customers may become harder if Demand softens. The RF exit and China Withdrawal are removing revenue while the Malaysia commissioning adds execution risk and working capital.

Net debt is rising again in the near term and reported 2025 earnings were a loss. Shareholders also registered dissent at the 23 April 2026 AGM, with the remuneration report receiving 76.13% support, prompting changes to the 2026 Bonus structure announced on 26 August 2026.

Outlook

XP Power enters the second half of 2026 with its strongest order book in four years, a leaner manufacturing footprint and a balance sheet in far better shape than at the start of 2025. Whether the year marks a genuine turning point depends on converting orders into shipments through the new Asian plants, holding the 45.9% gross margin as volumes rise, and bringing leverage towards 1.0x by December as guided. The Comet retrial, the third-quarter trading update and any signal on dividend reinstatement are the items to monitor before the full-year results in early 2027.